MyndTec Announces Investor Relations Agreement with Venture North Capital
MyndTec Announces Investor Relations Agreement with Venture North Capital
Mississauga, Ontario--(Newsfile Corp. - May 3, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce that it has entered into a consulting agreement (the "Consulting Agreement") with Venture North Capital Inc. ("Venture North") to provide strategic marketing, investor relations and capital markets communications services to the Company in compliance with the policies and guidelines of the Canadian Securities Exchange (the "CSE"). Venture North will arrange and attend meetings with professional investors, maintain ongoing contact and broaden relationships with the professional investment community on MyndTec's behalf.
安大略省密西索加-(Newsfile Corp.-2022年5月3日)-MyndTec Inc.(CSE:MYTC)(“联合科技公司“或”公司)很高兴地宣布,它已与北方风险投资公司(“北方风险投资”)签订了一项咨询协议(“咨询协议”),根据加拿大证券交易所(CSE)的政策和指导方针,为公司提供战略营销、投资者关系和资本市场沟通服务。北方风险投资公司将代表MyndTec安排和出席与专业投资者的会议,保持持续联系,并扩大与专业投资界的关系。
The Consulting Agreement is effective May 3, 2022 for an initial 3-month period ending July 31, 2022, after which it will continue in effect on a monthly basis until terminated upon 30 days written notice given by either the Company or Venture North. Pursuant to the Consulting Agreement, the Company will pay Venture North $6,000 plus applicable taxes per month and grant Venture North 200,000 stock options (the "Options") of the Company. Each Option is exercisable into one common share (each, a "Share") of the Company at an exercise price of $0.95 per Share and the Options will vest at a rate of 25% per quarter. All vested Options shall be eligible for exercise for a period expiring on the 10th anniversary of the grant date provided that all unvested Options will terminate and expire on the date that the Consulting Agreement is terminated.
咨询协议于2022年5月3日生效,最初为期3个月,截至2022年7月31日,之后将继续按月生效,直至本公司或Venture North发出30天书面通知后终止。根据咨询协议,本公司将每月向Venture North支付6,000美元外加适用税金,并授予Venture North 200,000份本公司股票期权(“期权”)。每项购股权可行使为一股本公司普通股(每股,“股份”),行使价为每股0.95美元,认购权将以每季度25%的速度授予。所有既得期权均有资格在10月10日到期的期限内行使。这是如果所有未授出的期权将在咨询协议终止之日终止和失效,则为授予日的周年纪念日。
About MyndTec
关于MyndTec
MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries. The Company develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injury specifically targeted to markets with large, growing and global patient populations. The Company's flagship product MyndMove™ is a non-invasive functional electrical stimulation-based intervention. MyndMove™ uses neuroplasticity mechanisms to stimulate development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living. The MyndMove™ system offers trained therapists the ability to assist individuals affected with paralysis to improve voluntary control of their limbs. The MyndMove™ therapy system offers a broad spectrum of sophisticated functional electrical stimulation software protocols which therapists customize to patient needs to enable meaningful controlled movements via proprietary stimulation technology.
MyndTec是一家加拿大医疗技术公司,致力于创新产品的开发和商业化,这些产品可以改善功能,最大限度地提高独立性,并提高因中风、脊髓损伤和某些创伤性脑损伤而遭受中枢神经系统损伤的个人的生活质量。该公司开发非侵入性神经和神经系统电刺激疗法,用于治疗神经系统疾病和损伤,专门针对拥有大量、不断增长的全球患者群体的市场。该公司的旗舰产品MyndMove™是一种基于电刺激的非侵入性功能性干预产品。MyndMove™使用神经可塑性机制来刺激新的神经传出和传入路径的发展,使患者能够重新建立自愿运动,并提高他们日常生活活动的独立性。MyndMove™系统为训练有素的治疗师提供了帮助瘫痪患者改善对其肢体的自愿控制的能力。MyndMove™治疗系统提供了一系列复杂的功能性电刺激软件协议,治疗师根据患者的需要进行定制,通过专有的刺激技术实现有意义的可控运动。
For more information visit
有关更多信息,请访问
Contact Information
联系信息
Craig Leon
MyndTec Inc. | Chief Executive Officer
investor.relations@myndtec.com
Tel: (416) 569-0430
克雷格·利昂
MyndTec Inc.|首席执行官
邮箱:investor.relationship@myndtec.com
电话:(416)569-0430
Bill Mitoulas
Venture North Capital Inc. | Principal
billm@venturenorthcapital.com
Tel: (416) 479-9547
比尔·米图拉斯
Venture North Capital Inc.|负责人
邮箱:billm@venturenorecapal.com
电话:(416)479-9547
Cautionary Note Regarding Forward-Looking Statements
有关前瞻性陈述的注意事项
This news release contains forward-looking statements that constitute "forward-looking information" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). All statements in this news release that are not historical facts are forward-looking statements, including, but not limited to, all statements regarding: events, performance or results of operations that the Company believes, expects or anticipates will or may occur in the future; the duration of the Consulting Agreement, the services provided under the Consulting Agreement; and the consideration paid pursuant to the Consulting Agreement. Forward-looking statements are typically, but not always, identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "could", "continue", "would", "will", "potential", "scheduled", "goal", "target", or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.
本新闻稿包含前瞻性陈述,构成适用加拿大证券法的“前瞻性信息”(统称为“前瞻性陈述“)。本新闻稿中所有非历史事实的陈述均为前瞻性陈述,包括但不限于以下所有陈述:公司相信、预期或预期未来将或可能发生的事件、业绩或经营结果;咨询协议的期限;根据咨询协议提供的服务;以及根据咨询协议支付的对价。前瞻性陈述通常但并非总是由下列词语来标识:“相信”、“预期”、“目标”、“预期”、“打算”、“估计”、“计划”、“可能”、“应该”、“可能”、“继续”、“将”、“将”、“可能”、“预定”、“目标”、“目标”或此类词语和短语的变体以及类似的表述,这些词语和短语的本质是指可能、可能、将、可能或将会发生、被采取或实现。
Forward-looking statements are necessarily based on a number of estimates and assumptions that include, but are not limited to: expected future development; general economic conditions; the ability of the Company to execute on its business objectives; and other estimates and assumptions described in the Company's Listing Statement dated February 18, 2022 (the "Listing Statement"), a copy of which is available under the Company's profile on SEDAR at . Forward-looking statements are inherently subject to a number of significant risks and uncertainties that could cause the actual results or events to differ materially from those described in the forward-looking statements. Important risks and uncertainties that could cause actual results or events to differ materially from expectations include, but are not limited to: the Company's ability to continue as a going concern, the Company's research, development and commercialization of its products could be stopped or delayed if any third party fails to provide sufficient quantities of products or components, or fails to do so at acceptable quality levels or prices, or fails to maintain or achieve satisfactory regulatory compliance; the Company expects to incur significant ongoing costs and obligations relating to its investment in infrastructure, growth, research and development, regulatory compliance and operations; and other risks and uncertainties described in the Listing Statement. The Company has attempted to identify important factors that could cause actual results, performance or achievements to vary from those expectations expressed or implied by the forward-looking statements, however, there may be other factors that cause results, performance or achievements not to be as expected and that could cause actual results, performance or achievements to differ materially from current expectations. These forward-looking statements are only current as of the date of this news release. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties and the Company provides no assurance that they will prove to be correct. Readers should not place undue reliance on such forward-looking statements. The Company does not undertake any obligation to update forward-looking statements contained herein, other than as required by applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.
前瞻性陈述必须基于若干估计和假设,这些估计和假设包括但不限于:预期的未来发展;总体经济状况;公司执行其业务目标的能力;以及公司于2022年2月18日的上市声明(“上市声明”)中描述的其他估计和假设。上市声明“),其副本可在SEDAR上的公司简介下查阅,网址为:。前瞻性陈述固有地受到许多重大风险和不确定因素的影响,这些风险和不确定因素可能导致实际结果或事件与前瞻性陈述中所描述的大不相同。可能导致实际结果或事件与预期大不相同的重要风险和不确定因素包括但不限于:如果任何第三方未能提供足够数量的产品或部件,或未能以可接受的质量水平或价格这样做,或未能维持或实现令人满意的监管合规,公司作为持续经营企业继续经营的能力,公司的产品研究、开发和商业化可能会停止或推迟;公司预计将产生与其基础设施投资、增长、研发、监管合规和运营相关的重大持续成本和义务;以及上市声明中描述的其他风险和不确定性。公司试图确定可能导致实际结果、业绩或成就与前瞻性陈述明示或暗示的预期不同的重要因素,然而,可能存在其他因素导致结果、业绩或成就与预期不符,可能导致实际结果、业绩或成就与当前预期大不相同。这些前瞻性陈述仅是截至本新闻稿发布之日的最新情况。尽管本公司认为该等前瞻性陈述所反映的预期是合理的, 此类陈述涉及风险和不确定因素,公司不能保证这些陈述将被证明是正确的。读者不应过分依赖这种前瞻性陈述。除适用法律要求外,公司不承担更新本文中包含的前瞻性陈述的任何义务。所有前瞻性陈述均受本警告性声明的限制。
The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
CSE绝不传递本公司业务的优点,既不批准或不批准本新闻稿的内容,也不对本新闻稿的充分性或准确性承担任何责任。
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
不得分发给美国新闻通讯社或在美国境内传播。
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问